Leucine, a B2B software-as-a-service start-up, has secured $7 million in a Series A funding round. The round was led by Ecolab Inc. and included participation from Pravega Ventures, Axilor Ventures, Techstars, and angel investors. The investment aims to fast-track the development of Leucine's Compliance Cloud platform and its artificial intelligence (AI)-driven tools tailored for the pharmaceutical manufacturing sector. In addition, the firm has announced the beta launch of Leucine10x, an AI framework intended to assist in pharmaceutical manufacturing processes.

https://www.business-standard.com/companies/news/ai-startup-leucine-gets-7-mn-funding-from-ecolab-inc-angel-investors-123101601062_1.html